Sorrento Therapeutics, Inc.
Sorrento CEO to Present at Upcoming Investor Conferences
SAN DIEGO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in upcoming investor...
Gilat Satellite Networks Ltd.
Gilat Awarded $10 Million for a Five-Year Project for 3G/4G Backhaul Services in Peru
PETAH TIKVA, Israel, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced...
Research and Markets
Global $18B Quantum Technology Market Forecast, 2024 - Quantum Communication Market Will Grow at the Highest CAGR During 2019-2024
Dublin, Nov. 12, 2019 (GLOBE NEWSWIRE) -- The "Quantum Technology Market: Computing, Communications, Imaging, Security, Sensing, Modeling and Simulation 2019-2024" report has been added to ...
Kandi Technologies Group, Inc.
Kandi Technologies Reports Third Quarter 2019 Financial Results
JINHUA, China, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (the “Company,” “we” or “Kandi”) (NASDAQ GS: KNDI), today announced its financial results for the third quarter of...
Editas Medicine, Inc.
Editas Medicine Announces Third Quarter 2019 Results and Update
Amended Celgene collaboration to focus on engineered alpha-beta T cell medicines with a $70 million payment to Editas Medicine Appointed Judith R. Abrams, M.D., as Chief Medical Officer EDIT-101...
Forty Seven, Inc.
Forty Seven, Inc. Reports Third Quarter 2019 Financial Results and Recent Business Highlights
-- On-Track to Initiate Potential Registration-Enabling Trials in MDS and DLBCL in 1Q 2020 ---- Entered into Collaboration with bluebird bio to Evaluate Antibody-Based Conditioning Regimen in...
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Fragile X Syndrome with Transdermal Cannabidiol
DEVON, Pa., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare...
Contango Oil & Gas
Contango Announces Third Quarter 2019 Financial Results and Provides Operational Update
HOUSTON, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) announced today its financial results for the third quarter ended...
Cronos Group Inc.
Cronos Group Inc. Announces Third Quarter 2019 Results
Closed Redwood U.S. Hemp-Based Products Platform and Cronos Fermentation Facility Acquisitions Announced the launch PEACE+™, A New Hemp-Derived U.S. Brand Advanced Operational Readiness of Cronos...
Lithium Americas
Lithium Americas Reports Third Quarter 2019 Results
VANCOUVER, British Columbia, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) ("Lithium Americas" or the "Company") has announced its financial and operating results...